Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Location
9237 E Via De Ventura Blvd., Suite 105, Scottsdale, AZ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % +12.3%
Quick Ratio 34.6 % +36.1%
Debt-to-equity 332 % -3.08%
Return On Equity -48.7 % -995%
Return On Assets -11.3 % -1017%
Operating Margin -24.4 % -831%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 50.1M USD +309%
Weighted Average Number of Shares Outstanding, Basic 23.3M shares +16.5%
Weighted Average Number of Shares Outstanding, Diluted 23.3M shares +16.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56.1M USD -29.1%
Revenue from Contract with Customer, Excluding Assessed Tax 55.4M USD -5.18%
Cost of Revenue 20.9M USD -8.8%
Research and Development Expense 2.01M USD -85%
Costs and Expenses 63.3M USD -16.3%
Operating Income (Loss) -6.86M USD -423%
Nonoperating Income (Expense) -1.76M USD -65.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.62M USD -910%
Income Tax Expense (Benefit) 60K USD
Net Income (Loss) Attributable to Parent -8.74M USD -1137%
Earnings Per Share, Basic 0 USD/shares -400%
Earnings Per Share, Diluted 0 USD/shares -400%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.3M USD -15.1%
Accounts Receivable, after Allowance for Credit Loss, Current 15.6M USD +49.5%
Inventory, Net 12.9M USD +32.7%
Assets, Current 51.3M USD +10.3%
Operating Lease, Right-of-Use Asset 156K USD +184%
Intangible Assets, Net (Excluding Goodwill) 29.7M USD +59.4%
Other Assets, Noncurrent 6K USD 0%
Assets 81.2M USD +24.5%
Accounts Payable, Current 12.8M USD -12.7%
Accrued Liabilities, Current 22.6M USD +41.2%
Liabilities, Current 40.5M USD +18.6%
Operating Lease, Liability, Noncurrent 69K USD
Liabilities 61.9M USD +14.9%
Retained Earnings (Accumulated Deficit) -94.9M USD -10.1%
Stockholders' Equity Attributable to Parent 19.2M USD +70.4%
Liabilities and Equity 81.2M USD +24.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.83M USD +43.6%
Net Cash Provided by (Used in) Financing Activities 3.6M USD +120%
Net Cash Provided by (Used in) Investing Activities -5M USD +75%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 765K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.3M USD -15.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 813K USD +204%
Deferred Tax Assets, Valuation Allowance 24M USD +19.3%
Deferred Tax Assets, Gross 24.1M USD +19.4%
Operating Lease, Liability 165K USD +180%
Lessee, Operating Lease, Liability, to be Paid 174K USD +190%
Operating Lease, Liability, Current 96K USD +62.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 105K USD +1067%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9K USD +800%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.81M USD +55.7%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 114M USD +17.1%
Amortization of Intangible Assets 1.06M USD +30.7%
Deferred Tax Assets, Net of Valuation Allowance 50K USD +100%
Share-based Payment Arrangement, Expense 5.68M USD +36.2%
Interest Expense 1.6M USD -30%